Business Context and Reporting Period
This Form 8-K was filed by Pluristem Therapeutics Inc. (formerly Pluristem Life Systems, Inc.) on November 26, 2007. The report covers corporate actions effective as of the filing date, specifically a reverse stock split and a change of corporate name.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate structural changes rather than financial performance data.
Material Changes
- Reverse Stock Split: The registrant announced the effectiveness of a reverse stock split.
- Name Change: The company officially changed its name from Pluristem Life Systems, Inc. to Pluristem Therapeutics Inc.
- Trading Symbol: A new trading symbol was adopted effective November 26, 2007.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It serves solely to notify the market of the name change and stock split, referencing a press release (Exhibit 99.1) for further details.
Investor Verification Checklist
- Verify the specific ratio of the reverse stock split in the attached press release (Exhibit 99.1).
- Confirm the new trading symbol assigned to the company.
- Check subsequent filings for updated share count and capitalization following the split.